Gene · 5976
Papers2,361
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,361
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors. | Nat Commun | 2022 | 36171202 | PubTator, text mining | PubMed |
| Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. | World J Gastroenterol | 2022 | 36161051 | PubTator, text mining | PubMed |
| Long noncoding RNA ZNFX1-AS1 promotes the invasion and proliferation of gastric cancer cells by regulating LIN28 and CAPR1N1. | World J Gastroenterol | 2022 | 36160641 | PubTator, text mining | PubMed |
| Anti-Prion Systems in Saccharomyces cerevisiae Turn an Avalanche of Prions into a Flurry. | Viruses | 2022 | 36146752 | PubTator, text mining | PubMed |
| Diverse Roles of the Exon Junction Complex Factors in the Cell Cycle, Cancer, and Neurodevelopmental Disorders-Potential for Therapeutic Targeting. | Int J Mol Sci | 2022 | 36142288 | PubTator, text mining | PubMed |
| SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms. | Genes (Basel) | 2022 | 36140826 | PubTator, text mining | PubMed |
| mRNA Metabolism in Health and Disease. | Biomedicines | 2022 | 36140363 | PubTator, text mining | PubMed |
| Anti-Prion Systems Block Prion Transmission, Attenuate Prion Generation, Cure Most Prions as They Arise and Limit Prion-Induced Pathology in Saccharomyces cerevisiae. | Biology (Basel) | 2022 | 36138748 | PubTator, text mining | PubMed |
| Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review. | Int J Biol Macromol | 2022 | 36130641 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Widespread autogenous mRNA-protein interactions detected by CLIP-seq. | Nucleic Acids Res | 2022 | 36107779 | PubTator, text mining | PubMed |
| TRIM proteins in hepatocellular carcinoma. | J Biomed Sci | 2022 | 36100865 | PubTator, text mining | PubMed |
| Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. | Nat Cell Biol | 2022 | 36075972 | PubTator, text mining | PubMed |
| Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors. | Front Pharmacol | 2022 | 36071844 | PubTator, text mining | PubMed |
| Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes. | PLoS Pathog | 2022 | 36067236 | PubTator, text mining | PubMed |
| Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19. | Eur J Med Chem Rep | 2022 | 36060987 | PubTator, text mining | PubMed |
| Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. | Nat Commun | 2022 | 36057605 | PubTator, text mining | PubMed |
| The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. | Mol Cancer | 2022 | 36056355 | PubTator, text mining | PubMed |
| Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection. | Front Mol Biosci | 2022 | 36052163 | PubTator, text mining | PubMed |
| NF90 interacts with components of RISC and modulates association of Ago2 with mRNA. | BMC Biol | 2022 | 36050755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5976/papers?page=22